Home › Funds › Saturn V Capital Management LP › IMMX
Saturn V Capital Management LP position in IMMX
IMMIX BIOPHARMA INC COM · Health Care
Saturn V Capital Management LP reported holding 4,658,429 shares of IMMX (IMMIX BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$48.0M, representing 6.89% of its reported portfolio and ranking #5 among its reported holdings. Saturn V Capital Management LP has disclosed IMMX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Saturn V Capital Management LP's IMMX position evolved
Saturn V Capital Management LP first disclosed a stake in IMMX in Q4 2025 at 2,999,169 shares (US$15.7M). The position peaked in Q2 2026 at 4,658,429 shares, worth US$48.0M. Across 3 filings, Saturn V Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,658,429 shares valued at US$48.0M — an increase of 964,844 shares quarter over quarter.. Notable position changes include a 26% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 3.00M | $15.69M | New |
| Q1 2026 | 3.69M | $33.65M | Add |
| Q2 2026 | 4.66M | $48.03M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC COM) is a Health Care company. 94 other funds we track also report a position in IMMX — the largest reported positions include Deep Track Capital, LP (US$28.6M), Opaleye Management Inc. (US$24.2M), GREAT POINT PARTNERS LLC (US$13.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- Deep Track Capital, LP 2.77M sh · $28.61M · Q2 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.19M · Q2 2026
- Bleichroeder LP 1.00M sh · $10.31M · Q2 2026
- Logos Global Management LP 1.00M sh · $10.31M · Q2 2026
- Blue Owl Capital Holdings LP 437.55K sh · $4.51M · Q2 2026
- KVP Capital Advisors, LP 230.42K sh · $2.38M · Q2 2026
- Imprint Wealth LLC 26.23K sh · $270.46K · Q2 2026
More on Saturn V Capital Management LP
FAQ
How long has Saturn V Capital Management LP held IMMX?
Saturn V Capital Management LP has disclosed IMMX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Saturn V Capital Management LP's current position in IMMX?
As of Q2 2026, Saturn V Capital Management LP holds 4.66M shares of IMMX (IMMIX BIOPHARMA INC COM), valued at $48.03M, representing 6.89% of its reported portfolio and ranking #5.
Has Saturn V Capital Management LP been buying or selling IMMX?
In the latest 13F filing (Q2 2026), Saturn V Capital Management LP increased its position in IMMX. The position peaked in Q2 2026 at 4.66M shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include Deep Track Capital, LP, Opaleye Management Inc., GREAT POINT PARTNERS LLC, among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.